• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

FDA clears commercial optical coherence tomography device

Article

The FDA has cleared Heidelberg Engineering GmbH's SL-OCT. According to the company, this is the world's first commercial optical coherence tomography (OCT) device used for cross-sectional anterior segment imaging.

The SL-OCT provides easy-to-use, non-contact cross-sectional scans of the anterior segment. Also possible are measurements of chamber angle, pachymetry, flap thickness, corneal curvature, and comprehensive biometrics, as well as pre- and post-surgical comparisons.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.